{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:44:07Z","timestamp":1794321847682,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T00:00:00Z","timestamp":1401235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00109-014-1170-1","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T01:38:35Z","timestamp":1401154715000},"page":"1069-1082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":443,"title":["NLRP3 inflammasome activation is required for fibrosis development in NAFLD"],"prefix":"10.1007","volume":"92","author":[{"given":"Alexander","family":"Wree","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"McGeough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla A.","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schlattjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia","family":"Inzaugarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Canbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel E.","family":"Feldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,28]]},"reference":[{"key":"1170_CR1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.2011.04145.x","volume":"61","author":"AP Levene","year":"2012","unstructured":"Levene AP, Goldin RD (2012) The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology 61:141\u2013152","journal-title":"Histopathology"},{"key":"1170_CR2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274\u2013285","journal-title":"Aliment Pharmacol Ther"},{"key":"1170_CR3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cld.2012.05.003","volume":"16","author":"SE Mahady","year":"2012","unstructured":"Mahady SE, George J (2012) Management of nonalcoholic steatohepatitis: an evidence-based approach. Clin Liver Dis 16:631\u2013645","journal-title":"Clin Liver Dis"},{"key":"1170_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113\u2013121","journal-title":"Gastroenterology"},{"key":"1170_CR5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413\u20131419","journal-title":"Gastroenterology"},{"key":"1170_CR6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1089-3261(02)00002-8","volume":"6","author":"EM Brunt","year":"2002","unstructured":"Brunt EM (2002) Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 6:399\u2013420, vii","journal-title":"Clin Liver Dis"},{"key":"1170_CR7","first-page":"583","volume":"99","author":"MC Hjelkrem","year":"2008","unstructured":"Hjelkrem MC, Torres DM, Harrison SA (2008) Nonalcoholic fatty liver disease. Minerva Med 99:583\u2013593","journal-title":"Minerva Med"},{"key":"1170_CR8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","volume":"56","author":"LP Bechmann","year":"2012","unstructured":"Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A (2012) The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 56:952\u2013964","journal-title":"J Hepatol"},{"key":"1170_CR9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000318741","volume":"83","author":"A Wree","year":"2011","unstructured":"Wree A, Kahraman A, Gerken G, Canbay A (2011) Obesity affects the liver\u2014the link between adipocytes and hepatocytes. Digestion 83:124\u2013133","journal-title":"Digestion"},{"key":"1170_CR10","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52:1836\u20131846","journal-title":"Hepatology"},{"key":"1170_CR11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417\u2013426","journal-title":"Mol Cell"},{"key":"1170_CR12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1001976","volume":"364","author":"MG Netea","year":"2011","unstructured":"Netea MG, van der Meer JW (2011) Immunodeficiency and genetic defects of pattern-recognition receptors. N Engl J Med 364:60\u201370","journal-title":"N Engl J Med"},{"key":"1170_CR13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805\u2013820","journal-title":"Cell"},{"key":"1170_CR14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","volume":"57","author":"G Szabo","year":"2012","unstructured":"Szabo G, Csak T (2012) Inflammasomes in liver diseases. J Hepatol 57:642\u2013654","journal-title":"J Hepatol"},{"key":"1170_CR15","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","volume":"143","author":"P Kubes","year":"2012","unstructured":"Kubes P, Mehal WZ (2012) Sterile inflammation in the liver. Gastroenterology 143:1158\u20131172","journal-title":"Gastroenterology"},{"key":"1170_CR16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jhep.2011.01.048","volume":"55","author":"Y Kamari","year":"2011","unstructured":"Kamari Y, Shaish A, Vax E, Shemesh S, Kandel-Kfir M, Arbel Y, Olteanu S, Barshack I, Dotan S, Voronov E et al (2011) Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol 55:1086\u20131094","journal-title":"J Hepatol"},{"key":"1170_CR17","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1002\/pmic.200800761","volume":"9","author":"B Roos de","year":"2009","unstructured":"de Roos B, Rungapamestry V, Ross K, Rucklidge G, Reid M, Duncan G, Horgan G, Toomey S, Browne J, Loscher CE et al (2009) Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics 9:3244\u20133256","journal-title":"Proteomics"},{"key":"1170_CR18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/labinvest.2012.45","volume":"92","author":"LJ Dixon","year":"2012","unstructured":"Dixon LJ, Berk M, Thapaliya S, Papouchado BG, Feldstein AE (2012) Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis. Lab Investig J Tech Methods Pathol 92:713\u2013723","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"1170_CR19","doi-asserted-by":"crossref","unstructured":"Wree A, Eguchi A, McGeough MD, Pena CA, Johnson CD, Canbay A, Hoffman HM, Feldstein AE (2013) NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation and fibrosis. Hepatology 59:898\u2013910","DOI":"10.1002\/hep.26592"},{"key":"1170_CR20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1053\/j.gastro.2009.06.045","volume":"137","author":"Y Kodama","year":"2009","unstructured":"Kodama Y, Kisseleva T, Iwaisako K, Miura K, Taura K, De Minicis S, Osterreicher CH, Schnabl B, Seki E, Brenner DA (2009) c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology 137:1467\u20131477, e1465","journal-title":"Gastroenterology"},{"key":"1170_CR21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2006.02.004","volume":"24","author":"FS Sutterwala","year":"2006","unstructured":"Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, Bertin J, Coyle AJ, Galan JE, Askenase PW et al (2006) Critical role for NALP3\/CIAS1\/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24:317\u2013327","journal-title":"Immunity"},{"key":"1170_CR22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2009.05.005","volume":"30","author":"SD Brydges","year":"2009","unstructured":"Brydges SD, Mueller JL, McGeough MD, Pena CA, Misaghi A, Gandhi C, Putnam CD, Boyle DL, Firestein GS, Horner AA et al (2009) Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 30:875\u2013887","journal-title":"Immunity"},{"key":"1170_CR23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/dbio.2002.0597","volume":"244","author":"S Hayashi","year":"2002","unstructured":"Hayashi S, McMahon AP (2002) Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation\/inactivation in the mouse. Dev Biol 244:305\u2013318","journal-title":"Dev Biol"},{"key":"1170_CR24","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.4049\/jimmunol.1101737","volume":"189","author":"MD McGeough","year":"2012","unstructured":"McGeough MD, Pena CA, Mueller JL, Pociask DA, Broderick L, Hoffman HM, Brydges SD (2012) Cutting edge: IL-6 is a marker of inflammation with no direct role in inflammasome-mediated mouse models. J Immunol 189:2707\u20132711","journal-title":"J Immunol"},{"key":"1170_CR25","first-page":"5042","volume":"52","author":"D Nakae","year":"1992","unstructured":"Nakae D, Yoshiji H, Mizumoto Y, Horiguchi K, Shiraiwa K, Tamura K, Denda A, Konishi Y (1992) High incidence of hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats. Cancer Res 52:5042\u20135045","journal-title":"Cancer Res"},{"key":"1170_CR26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/CS20120542","volume":"125","author":"A Kahraman","year":"2013","unstructured":"Kahraman A, Sowa JP, Schlattjan M, Sydor S, Pronadl M, Wree A, Beilfuss A, Kilicarslan A, Altinbas A, Bechmann LP et al (2013) Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients. Clin Sci 125:391\u2013400","journal-title":"Clin Sci"},{"key":"1170_CR27","doi-asserted-by":"crossref","unstructured":"Kalsch J, Bechmann LP, Kalsch H, Schlattjan M, Erhard J, Gerken G, Canbay A (2011) Evaluation of biomarkers of NAFLD in a cohort of morbidly obese patients. J Nutr Metab 2011: 369168. doi: 10.1155\/2011\/369168","DOI":"10.1155\/2011\/369168"},{"key":"1170_CR28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321","journal-title":"Hepatology"},{"key":"1170_CR29","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","volume":"122","author":"J Petrasek","year":"2012","unstructured":"Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min SY, Kurt-Jones EA, Szabo G (2012) IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 122:3476\u20133489","journal-title":"J Clin Invest"},{"issue":"323\u2013334","key":"1170_CR30","first-page":"e327","volume":"139","author":"K Miura","year":"2010","unstructured":"Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA, Seki E (2010) Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 139(323\u2013334):e327","journal-title":"Gastroenterology"},{"key":"1170_CR31","doi-asserted-by":"crossref","first-page":"e56100","DOI":"10.1371\/journal.pone.0056100","volume":"8","author":"LJ Dixon","year":"2013","unstructured":"Dixon LJ, Flask CA, Papouchado BG, Feldstein AE, Nagy LE (2013) Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. PLoS One 8:e56100","journal-title":"PLoS One"},{"key":"1170_CR32","doi-asserted-by":"crossref","first-page":"G1248","DOI":"10.1152\/ajpgi.90223.2008","volume":"296","author":"A Watanabe","year":"2009","unstructured":"Watanabe A, Sohail MA, Gomes DA, Hashmi A, Nagata J, Sutterwala FS, Mahmood S, Jhandier MN, Shi Y, Flavell RA et al (2009) Inflammasome-mediated regulation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 296:G1248\u2013G1257","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1170_CR33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12:408\u2013415","journal-title":"Nat Immunol"},{"key":"1170_CR34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17:179\u2013188","journal-title":"Nat Med"},{"key":"1170_CR35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ et al (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482:179\u2013185","journal-title":"Nature"},{"key":"1170_CR36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbi.2008.09.001","volume":"23","author":"AF Eisener-Dorman","year":"2009","unstructured":"Eisener-Dorman AF, Lawrence DA, Bolivar VJ (2009) Cautionary insights on knockout mouse studies: the gene or not the gene? Brain Behav Immun 23:318\u2013324","journal-title":"Brain Behav Immun"},{"key":"1170_CR37","doi-asserted-by":"crossref","first-page":"E429","DOI":"10.1152\/ajpendo.00124.2006","volume":"291","author":"RA Davey","year":"2006","unstructured":"Davey RA, MacLean HE (2006) Current and future approaches using genetically modified mice in endocrine research. Am J Physiol Endocrinol Metab 291:E429\u2013E438","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1170_CR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","volume":"54","author":"T Csak","year":"2011","unstructured":"Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G (2011) Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54:133\u2013144","journal-title":"Hepatology"},{"key":"1170_CR39","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1194\/jlr.M600198-JLR200","volume":"47","author":"G Rizki","year":"2006","unstructured":"Rizki G, Arnaboldi L, Gabrielli B, Yan J, Lee GS, Ng RK, Turner SM, Badger TM, Pitas RE, Maher JJ (2006) Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J Lipid Res 47:2280\u20132290","journal-title":"J Lipid Res"},{"key":"1170_CR40","doi-asserted-by":"crossref","first-page":"e6066","DOI":"10.1371\/journal.pone.0006066","volume":"4","author":"MH Oosterveer","year":"2009","unstructured":"Oosterveer MH, van Dijk TH, Tietge UJ, Boer T, Havinga R, Stellaard F, Groen AK, Kuipers F, Reijngoud DJ (2009) High fat feeding induces hepatic fatty acid elongation in mice. PLoS One 4:e6066","journal-title":"PLoS One"},{"key":"1170_CR41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1054\/clnu.2001.0529","volume":"21","author":"IT Almeida de","year":"2002","unstructured":"de Almeida IT, Cortez-Pinto H, Fidalgo G, Rodrigues D, Camilo ME (2002) Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin Nutr 21:219\u2013223","journal-title":"Clin Nutr"},{"key":"1170_CR42","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","volume":"50","author":"P Puri","year":"2009","unstructured":"Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, Contos MJ, Sterling RK, Fuchs M, Zhou H et al (2009) The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 50:1827\u20131838","journal-title":"Hepatology"},{"key":"1170_CR43","doi-asserted-by":"crossref","unstructured":"Wree A, Bechmann LP, Claudel T, Schlattjan M, Sowa JP, Baba H, Gerken G, Feldstein AE, Trauner M, Canbay A (2013) Bariatric surgery reduces adipocyte size, improves liver injury and counteracts lipotoxicity via changes in serum fatty acid composition and adiponectin levels. J Hepatol 58:S553","DOI":"10.1016\/S0168-8278(13)61374-4"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-014-1170-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-014-1170-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-014-1170-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T00:33:40Z","timestamp":1565483620000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-014-1170-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,28]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["1170"],"URL":"https:\/\/doi.org\/10.1007\/s00109-014-1170-1","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,28]]}}}